MX2007004689A - Novel skin care formulation - Google Patents
Novel skin care formulationInfo
- Publication number
- MX2007004689A MX2007004689A MXMX/A/2007/004689A MX2007004689A MX2007004689A MX 2007004689 A MX2007004689 A MX 2007004689A MX 2007004689 A MX2007004689 A MX 2007004689A MX 2007004689 A MX2007004689 A MX 2007004689A
- Authority
- MX
- Mexico
- Prior art keywords
- formulation
- clause
- skin
- water
- cosmetically acceptable
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 137
- 210000003491 Skin Anatomy 0.000 title claims abstract description 70
- 238000009472 formulation Methods 0.000 title claims description 79
- 150000003839 salts Chemical class 0.000 claims abstract description 61
- 239000011780 sodium chloride Substances 0.000 claims abstract description 59
- 229910052751 metal Inorganic materials 0.000 claims abstract description 39
- 239000002184 metal Substances 0.000 claims abstract description 39
- 239000003921 oil Substances 0.000 claims abstract description 39
- 150000001768 cations Chemical class 0.000 claims abstract description 27
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 23
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 22
- 239000000194 fatty acid Substances 0.000 claims abstract description 22
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 20
- 230000003020 moisturizing Effects 0.000 claims abstract description 14
- 230000003750 conditioning Effects 0.000 claims abstract description 8
- 230000014759 maintenance of location Effects 0.000 claims abstract description 5
- 238000000151 deposition Methods 0.000 claims abstract description 3
- 238000001035 drying Methods 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 239000000839 emulsion Substances 0.000 claims description 26
- 239000004094 surface-active agent Substances 0.000 claims description 24
- 239000002253 acid Substances 0.000 claims description 23
- -1 fatty acid esters Chemical class 0.000 claims description 18
- 239000007762 w/o emulsion Substances 0.000 claims description 15
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 11
- 150000001298 alcohols Chemical class 0.000 claims description 10
- 150000002500 ions Chemical class 0.000 claims description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 9
- 150000007513 acids Chemical class 0.000 claims description 8
- 235000013871 bee wax Nutrition 0.000 claims description 8
- 239000012166 beeswax Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 239000001993 wax Substances 0.000 claims description 7
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 6
- 229940066842 Petrolatum Drugs 0.000 claims description 6
- 239000004264 Petrolatum Substances 0.000 claims description 6
- 235000021355 Stearic acid Nutrition 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 6
- 239000002480 mineral oil Substances 0.000 claims description 6
- 235000010446 mineral oil Nutrition 0.000 claims description 6
- 235000019271 petrolatum Nutrition 0.000 claims description 6
- 239000008117 stearic acid Substances 0.000 claims description 6
- 239000011787 zinc oxide Substances 0.000 claims description 6
- 229940057910 Shea butter Drugs 0.000 claims description 5
- 229940029983 VITAMINS Drugs 0.000 claims description 5
- 229940021016 Vitamin IV solution additives Drugs 0.000 claims description 5
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 5
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 5
- DJWUNCQRNNEAKC-UHFFFAOYSA-L Zinc acetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O DJWUNCQRNNEAKC-UHFFFAOYSA-L 0.000 claims description 5
- 230000000111 anti-oxidant Effects 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 150000002430 hydrocarbons Chemical class 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 229930003231 vitamins Natural products 0.000 claims description 5
- 239000004246 zinc acetate Substances 0.000 claims description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- 235000011148 calcium chloride Nutrition 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003205 fragrance Substances 0.000 claims description 4
- 150000004668 long chain fatty acids Chemical class 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 230000002335 preservative Effects 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 4
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 4
- 239000000516 sunscreening agent Substances 0.000 claims description 4
- KOYYEPZTIWTHDY-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;zinc;dihydrate Chemical compound O.O.[Zn].[Zn].[Zn].OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O KOYYEPZTIWTHDY-UHFFFAOYSA-N 0.000 claims description 3
- 239000004215 Carbon black (E152) Substances 0.000 claims description 3
- XMHIUKTWLZUKEX-UHFFFAOYSA-N Cerotic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 claims description 3
- 235000021314 Palmitic acid Nutrition 0.000 claims description 3
- 229940068475 ZINC CITRATE Drugs 0.000 claims description 3
- JIAARYAFYJHUJI-UHFFFAOYSA-L Zinc chloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 235000013904 zinc acetate Nutrition 0.000 claims description 3
- 239000011592 zinc chloride Substances 0.000 claims description 3
- 235000005074 zinc chloride Nutrition 0.000 claims description 3
- 239000011746 zinc citrate Substances 0.000 claims description 3
- 235000006076 zinc citrate Nutrition 0.000 claims description 3
- 235000014692 zinc oxide Nutrition 0.000 claims description 3
- 239000004902 Softening Agent Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 239000008367 deionised water Substances 0.000 claims description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000002708 enhancing Effects 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 description 26
- 229960001484 Edetic Acid Drugs 0.000 description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
- 239000002738 chelating agent Substances 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol;(Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 4
- 229940088710 Antibiotic Drugs 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- 229960005078 Sorbitan sesquioleate Drugs 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 229960004418 Trolamine Drugs 0.000 description 4
- 230000000844 anti-bacterial Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 239000007764 o/w emulsion Substances 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 229940029612 triethanolamine Drugs 0.000 description 4
- 238000009736 wetting Methods 0.000 description 4
- 229940068968 Polysorbate 80 Drugs 0.000 description 3
- CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 3
- 229960001452 alpha-Tocopherol Acetate Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- CYFUTQFVJKHZRW-UHFFFAOYSA-N 1,3,5,5-tetramethylimidazolidine-2,4-dione Chemical compound CN1C(=O)N(C)C(C)(C)C1=O CYFUTQFVJKHZRW-UHFFFAOYSA-N 0.000 description 2
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N DMDM hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene (PE) Substances 0.000 description 2
- 229940042585 Tocopherol Acetate Drugs 0.000 description 2
- 239000007765 cera alba Substances 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M palmitate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 230000000699 topical Effects 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-N (2E)-3-phenylprop-2-enoic acid Chemical class OC(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N 3-(2,3-dihydroxypropoxy)propane-1,2-diol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- OTWLSKFSMBYYGV-UHFFFAOYSA-N CN1C(=O)N(C(=O)C1(C(C)C)C)C Chemical compound CN1C(=O)N(C(=O)C1(C(C)C)C)C OTWLSKFSMBYYGV-UHFFFAOYSA-N 0.000 description 1
- 229940119217 Chamomile extract Drugs 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- PXRMLPZQBFWPCV-UHFFFAOYSA-N O1O[SiH2]1 Chemical compound O1O[SiH2]1 PXRMLPZQBFWPCV-UHFFFAOYSA-N 0.000 description 1
- 229940101267 Panthenol Drugs 0.000 description 1
- 229940055726 Pantothenic Acid Drugs 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 230000002292 Radical scavenging Effects 0.000 description 1
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- REZQBEBOWJAQKS-UHFFFAOYSA-N Triacontanol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO REZQBEBOWJAQKS-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229940046009 Vitamin E Drugs 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 235000014104 aloe vera supplement Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-M anthranilate Chemical class NC1=CC=CC=C1C([O-])=O RWZYAGGXGHYGMB-UHFFFAOYSA-M 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- QZZYOHURAFAUTB-UHFFFAOYSA-N hexacosyl hexacosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCCCCCCCCCC QZZYOHURAFAUTB-UHFFFAOYSA-N 0.000 description 1
- 150000002398 hexadecan-1-ols Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002045 lasting Effects 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N pantothenic acid Natural products OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002285 radioactive Effects 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000475 sunscreen Effects 0.000 description 1
- 230000002459 sustained Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002569 water oil cream Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Abstract
Skin moisturizing formulations which can be administered in the bath or shower, depositing a thin layer of moisturizing agents on application, which is not rinsed off but remains to protect the skin from drying, resulting in smoother, softer skin feel;the formulations comprising polyvalent metal cations and fatty acids, which react on application in the shower or bath to form a thin deposit of insoluble salts, thereby enhancing the retention of moisturizing oils and conditioning agents.
Description
FORMULATION FOR NEW SKIN CARE
Field of the Invention
This invention relates to novel skin care formulations containing low concentrations of long chain acids, for example, fatty acids and polyvalent metal ions, suitable for use in the bath or shower and capable of delivering wetting and other beneficial ingredients to the skin and provide an improved skin feeling after rinsing.
Background of the Invention
Skin care compositions, e.g., skin moisturizing compositions, are typically aqueous formulations comprising emulsified oil which is stabilized with the surfactant. Finally, the moisturizing compositions are better applied to the skin when the skin is wet and saturated with water, but less advantage of the conventional formulations in this aspect is that they are immediately and completely rinsed, applied in the shower or bath. Oil-based skin care formulations which are essentially free of surfactants, on the other hand, can resist rinsing, but form a relatively thick and aesthetically unpleasant layer of the oil on the skin.
There is a need for a skin care formulation which can be applied when the skin is wet, for example, in the shower or bath, but which can be essentially rinsed leaving a conditioning or moisturizing agent sufficient to protect the skin and provide a long lasting moisturizing effect.
Synthesis of the Invention
The present invention provides formulations for skin care which can be administered in the bath or fight by depositing a thin layer of moisturizer or other conditioning agents with the application, which are not rinsed, but remain to protect the skin of the skin. dryness, resulting in a softer and smoother skin feeling. The formulations of the invention comprise polyvalent metal cations and long-chain acids, which react with the application in the shower or bath to form a thin deposit of insoluble salts, thereby improving the retention of wetting oils and conditioning agents .
Detailed description of the invention
The invention provides a skin care formulation comprising: (i) cosmetically acceptable polyvalent metal cations (more particularly di-o-tri-valent metal cations (e.g., a cation selected from the group consisting of Ca ++, Zn ++ , Mg ++, Al +++, and mixtures of any of two or more of the above), especially transition metal ions, for example, as provided by the salt or cosmetically acceptable water-soluble salts of such cation or cations (more particularly one or more members selected from the group consisting of calcium chloride, zinc citrate, zinc chloride, zinc oxide, zinc acetate, magnesium sulfate and mixtures of two or more of the above) preferably the salt form being present in an amount of from 0.01 to 2% by weight of the total formulation;
(ii) cosmetically acceptable long chain acids capable of forming an insoluble salt with the polyvalent metal cation (particularly a transition metal cation) with examples of such long chain acids being straight branched chain saturated and unsaturated fatty acids having -40 carbons, particularly C16-30 saturated fatty acids, and particularly examples including one or more of palmitic acid, stearic acid, or ceric acid; the amounts of such long chain fatty acids being preferably in the range of 2 to 10% by weight of the total formulation;
(iii) a cosmetically acceptable water insoluble oil component in addition to the long chain fatty acid listed in (ii), particularly a member selected from the group consisting of:
to. cosmetically acceptable hydrocarbon oils, for example, mineral oil, petrolatum, hydrocarbons found in beeswax (for example C21-37 hydrocarbons, and mixtures of any of the foregoing, especially mixtures of from 1: 1 to 3: 1 oil mineral to oil by weight;
b. esters of fatty acids and long straight-chain alcohols, for example as found in beeswax, in polar wax, for example esters of straight chain C24-36 alcohols and Ci8-36 fatty acids, such as triacontanol hexadecanoate, hexacosanol hexacosanoate, and miricyl palmitate;
c. and optionally, lipophilic emollients, for example,
(i) long straight chain alcohols, for example, C12-34 straight chain alcohols, for example one or more of cetyl alcohol, stearyl alcohol, and alcohols found in beeswax and polar wax; and / or (ii) silicone oils, for example, dimethyl polysiloxane.
for example, the oil component being preferably present in an amount of from 25-60% by weight of the total formulation;
wherein the polyvalent metal cation is prevented from the substantial reaction with the long-chain acid while it is in the formulation (for example, it is in a substantially undissolved salt form, or the chain acid is essentially physically sequestered) long), but with the application of the formulation on the skin and the rinsing with water, it is capable of the reaction with the long-chain acid to form a thin layer of the insoluble precipitate on the skin.
By "skin care composition" is meant a composition which provides a therapeutic, prophylactic, or cosmetic benefit to the skin, including wetting and protecting the skin, thereby improving the condition or health of the skin, including for example the water-in-oil and oil and oil-in-water emulsion compositions.
By "cosmetically acceptable" is meant the use in a formulation for topical application to human skin. A cosmetically acceptable excipient, for example, is an excipient which is suitable for external application in the amounts and concentrations contemplated in the formulations of this invention, and includes, for example, excipients which are "generally recognized as safe" (GRAS). ) by the Food and Drug Administration of the United States of America. The radioactive elements, the heavy metals, and other materials which a person skilled in the art reasonably expected to be toxic for topical administration are excluded.
The formulation also comprises:
(i) a hydrophilic component, particularly a member of the group consisting of lower water and alkanes, for example, alkanols having 2-9 carbons such as ethanol, isopropanol, propylene glycol, glycerol, triglycerol, and mixtures of any of the foregoing; Y
(ii) one or more surfactants, for example, cosmetically acceptable nonionic surfactants such as to form an emulsion with the aforementioned fatty acids and the hydrocarbon oil, for example, a water-in-oil emulsion or an oil-emulsion. in-water, preferably a water-in-oil emulsion.
The surfactants for the emulsion formulations of this invention may comprise a combination of nonionic surfactants, for example, one or more surfactants selected from the group consisting of:
(i) lipophilic surfactants, for example, having a lipophilic hydrophilic balance value of 8 or lower, for example fatty acid sorbitan esters, such as sorbitan oleates, for example, sorbitan sesquioleate; Y
(ii) hydrophilic surfactants, for example, having a lipophilic hydrophilic balance of more than 8, particularly
to. di- or tri-alkanol amides such as triethanol amine;
b. polyethoxylated surfactants, for example, polyethoxylated alcohols (especially polyethoxylated polyols), polyethoxylated vegetable oils, and polyethoxylated silicones, for example, polysorbate 80, polyethylene dimethicone oxide and dimethylmethyl (polyethylene oxide) siloxane.
For a water-in-oil emulsion, the overall lipophilic hydrophilic balance of the surfactant mixture is preferably 2-8, for example, there is typically a higher proportion of lipophilic surfactant; while for an oil-in-water emulsion, the overall lipophilic hydrophilic balance of the surfactant mixture is preferably 8-16.
The formulation may further comprise preservatives, for example, chelators (e.g. edetic acid (EDTA), antibacterials (e.g., dimethyl-dimethyl-dimethyl-hydantoin (DMDMH) and / or antioxidants (e.g. tocopheryl acetate); perfumes; coloring agents and / or other excipients as is known in the art of cosmetics For example, the formulation may further comprise pharmaceutically or cosmetically active agents which provide a prophylactic or therapeutic, or cosmetic, benefit to the skin, for example.
(i) skin softening / conditioning agents, especially plant extracts, eg, shea butter, aloe vera extract, sweet almond oil, coconut oil, plant essential oils, eg, lavender oil, rosemary oil or chamomile extract;
(ii) vitamins, for example, B complex vitamins such as panthenol, pantothenic acid and its cosmetically acceptable salts, esters and derivatives; or free radical scavenging vitamins in addition to the antioxidants provided to stabilize the above formulation, eg, vitamin C, vitamin E, and their cosmetically acceptable salts, esters and derivatives;
(ii) antibacterials, for example dimethyl-dimethyl-hydantoin (DMDMH), trichlorocarban (TCC), or triclosan;
(iv) agents for the sunscreen, for example, p-aminobenzoic acid and its cosmetically acceptable salts, esters and derivatives, as well as sunscreen agents selected from cinnamates, benzophenes and anthranilates.
The pharmaceutically or cosmetically active agent is provided in a defective amount which will vary depending on the agent selected and the desired benefit, for example, from 0.1 to 5%.
As noted above, the formulation may further comprise preservatives, for example chelators (e.g., edetic acid (EDTA)), antibacterials, (e.g., dimethyl-dimethyl-hydantoin (DMDMH)) and / or antioxidants (e.g., tocopherol acetate); perfumes, coloring agents; and / or other excipients as known in the art of cosmetics.
It will be recognized by one skilled in the art that the thin residue left on the skin after the application of the formulations of the invention can be exploited to allow a sustained delivery of benefit agents to the skin, as well as pharmaceutical agents, particularly lipophilic agents. which will be deposited on the skin, as well as the moisturizing oils of the formulation. In this aspect of the invention this provides, for example, for moisturizing, protecting and / or conditioning the skin comprising applying a formulation of the invention to the skin and rinsing with water and a method for delivering a pharmaceutically or cosmetically active agent to the skin. skin comprising applying a skin care formulation as described herein, wherein the formulation comprises a defective amount of a pharmaceutically or cosmetically active agent.
Prior to the application of the formulation, the polyvalent metal cation is prevented from a substantial reaction with the long-chain acid while the formulation is, for example, the cation may be present in an essentially undissolved salt form or cation can be essentially physically sequestered from the long chain acid, with the application of the formulation to the skin and the rinsing with water, the cation is capable of reaction with the fatty acid to form a thin layer of an insoluble precipitate on the skin. The reaction of the cation with the long-chain acid before the application can therefore be minimized or avoided, for example (i) by encapsulating or coating the cosmetically acceptable salt or salts or the long chain acid or acids so that the capsule or coating is released with the application of the formulation, as in the presence of water or rubbed, for example, the encapsulation in water-soluble capsules, for example water-soluble polymer capsules or starch which by coating with a meltable coating, for example, mixing the salt with a melted wax then cools and pulverizes the mixture , so that the salt particles are coated with a wax coating which is stable in the formulation but which is dispersed and dissolved with the application in the presence of water;
(ii) by using a low or non-aqueous water formulation, particularly containing less than 20% and, more particularly containing less than 10% water by weight in order to avoid substantial solubilization of the cosmetically acceptable salt prior to application so that the cation is not free to react with the fatty acid before application; or
(III) by adding the cosmetically acceptable salt to a formulation after the oil and water components are essentially combined, so that any cosmetically acceptable salt is not essentially dissolved and is available for reaction with the acid (e.g. when the salt is added to the oil phase of an existing water-in-oil emulsion) or the acid is already sequestered in the oil phase and is therefore not available for reaction with the cation (for example, when the salt it is added to an existing oil-in-water emulsion).
The concentration of the polyvalent metal cation in the formulation of the invention is preferably low, for example less than 2%, for example 0.01-2%, more particularly 0.05-1% by weight of the cosmetically acceptable salt to the finished formulation, since the small amount is sufficient to allow the retention of wetting agents, while very high amounts can leave an aesthetically undesirable film on the skin. When the water-soluble salts are used or where the water content of the formulation is relatively low the salt concentration may be somewhat higher while the desirable properties of the formulation are retained, but the concentration must not generally exceed 2% by weight. The anions which are chelating agents may tend to inhibit the formation of metal salt of the fatty acid, since the constant formation of the metal chelate is typically greater than that of the metal salt of the fatty acid, therefore if the chelating agents are used in the formulation, for example as condoms, weaker chelators such as EDTA are preferred, with the concentration maintained at a relatively low level, particularly of less than 0.5% and more particularly, on the order of 0.05-0.15% , and / or the formulation is preferably designed to avoid substantial reactions between the cations and chelates prior to application, for example, analogous to the approaches described above to avoid a substantial reaction between the fatty acid and the cation prior to application, for example by sequestering the chelator cation or preventing substantial dissolution of the cation salt in the formulation before e the application.
In one embodiment, the invention provides a skin care product comprising, by weight:
(i) 0.01% to 2%, for example, 0.05% to 1%, of cosmetically acceptable salt of polyvalent metal ion as described above;
(ii) 2 to 10% of one or more long chain fatty acids as described above;
(iii) 25-60% of a cosmetically acceptable oil component as described above;
Wherein the cosmetically acceptable water-soluble salt is prevented from reacting with the fatty acid before application.
In another embodiment, the invention provides a wetting composition which is an emulsion, particularly a water-in-oil emulsion comprising:
(i) 0.01-2%, for example 0.5% to 1% of a cosmetically acceptable water soluble salt of a polyvalent metal ion as described above;
(ii) 2-10% fatty acid as described above;
(iii) 25-60% of a cosmetically acceptable oil component as described above;
(iv) 3-10% surfactant, preferably nonionic surfactant;
(v) 30-60% hydrophilic component as described above;
Wherein the cosmetically acceptable water-soluble salt is added after the emulsion has been formed.
For example, in a preferred embodiment, formulation is a water-in-oil emulsion comprising (i) one or more fatty acids as described above, (particularly in an amount of 1-4%);
(ii) a cosmetically acceptable oil component as described above particularly in an amount of 10-40%);
(iii) a hydrophilic component as described above (particularly of an amount of 30-50%); Y
(iv) one or more surfactants, preferably nonionic surfactants (particularly in an amount of 3-10%);
and further comprising a cosmetically acceptable salt of a polyvalent metal cation, preferably in an amount of 0.01 to 2%, for example 0.05 to 1%, which has been added after the emulsion has been formed.
In a particularly preferred embodiment, the formulation is a water-in-oil emulsion comprising by weight:
(i) 0.05-1% of a cosmetically acceptable salt of a selected polyvalent metal ion consisting of calcium chloride, zinc citrate, zinc chloride, zinc oxide, zinc acetate, and magnesium sulfate;
(ii) 1-8% saturated C16-30 fatty acids for example, one or more selected from palmitic acid, stearic acid, cerotic acid, and mixtures thereof, preferably stearic acid;
(iii) 2-10% beeswax, polar wax or mixtures thereof, preferably beeswax;
(iv) 20-30% mineral oil;
(v) 5-20% petrolatum;
(vi) 0.5-5% straight chain alcohols C12-34, cetyl alcohol, stearyl alcohol or mixtures thereof;
(vii) 30-45% deionized water;
(viii) 2-10% propylene glycol, glycerin or mixtures thereof;
(ix) 2-5% lipophilic surfactant, for example, sorbitan sesquioleate;
(x) 1-3% hydrophilic surfactant, for example, one or more members selected from di-o-tri-alkanol amine, polyethoxylated alcohol, polyethoxylated silicone, particularly one or more members selected from triethanol amine, polysorbate 80, and dimethyl methyl (polyethylene siloxane oxide;
(xi) 0.1-1% preservatives and antioxidants, for example one or more members selected from EDTA, DMDMH, and tocopherol acetate;
wherein the cosmetically acceptable salt has been added after the emulsion has already been formed;
wherein the formulation optionally further comprises one or more components selected from:
(i) 0.1-2% fragrance;
(ii) 0.05-0.5% coloring;
(iii) 0.1-5% skin benefit agent as described above, for example, selected from skin softening agents, vitamins, antibacterials, sunscreen agents and combinations thereof; for example, shea butter, particularly in an amount of 1.5-2.5%.
In a further embodiment, the invention provides a process for the preparation of a skin moisturizing formulation according to the invention, as described above, comprising adding the water soluble salt of polyvalent metal ion as described above. , to an emulsion, for example, a water-in-oil emulsion or an oil-in-water emulsion as described above.
For example, the invention provides a process for the preparation of a skin moisturizing formulation which is a water-in-oil emulsion comprising
(i) mixing the aqueous components of the formulation as described above, excluding the salt, one or more of propylene glycol water, glycerol, diglycerol and / or triglycerol, together with one or more hydrophilic surfactants; and separately mixing the lipophilic components as described above, for example, the long chain acid and the oil components, together with one or more lipophilic surfactants, at an elevated temperature, for example 60-95 degrees centigrade;
(ii) adding the aqueous mixture to the lipophilic mixture and homogenizing to form a water-in-oil emulsion;
(iii) cooling the emulsion, for example the temperature in the range of 20-50 degrees C;
(iv) adding the salt of the polyvalent metal ion to the emulsion and mixing so that the salt is suspended in the oil phase of the water-in-oil emulsion.
The formulations provided herein are based on ingredients used to make the formulation. It will be apparent to one skilled in the art that in some cases the component ingredients can overlap, for example beeswax contains the long chain alcohols and the fatty acids, as well as esters thereof, sorbitan sesquioleate can contain the acid oleic as an impurity or a degradation product, and others.
EXAMPLES
The following examples are intended to illustrate the invention, not to limit it and such variations of these exemplified formulations will be apparent to one skilled in the art that are within the scope of this invention.
Examples 1, Ia-1G, 2, 2a, 3 and 3 Water-in-Oil Emulsions
Table 1
The amounts of the table given above are given as a percentage by weight of the final formulation.
The above formulations are prepared as water-in-oil emulsions and the metal salts are added once the emulsion is complete. The metal metal salts are essentially undissolved in the continuous phase (oils) of the emulsions.
Formulations 1A-1G, and 2A are prepared as follows:
Part A (Water Phase)
Add water in a side container and start stirring and heating;
Add EDTA; mix and heat;
Add Polysorbate 80 (Tween 80), continue mixing and warming;
Add Propylene Glycol; continue mixed and heated:
Add Triethanolamine; continue mixed and heated:
Continue mixing and heating until a temperature of 80 ° C is reached Part B (Oil Phase)
The main container add shea butter
Add White Beeswax
Add Stearic Acid
Add Sorbitan Sesquioleate
Add Mineral Oil
Add Fluid DC 193
Add Petrolatum
Add Cetyl Stearyl Alcohol
Add Vitamin E Acetate
Heat and mix until it is homogeneous and reached at a temperature of 80 ° C.
Part C
When both phases have reached 80 ° C, and add to the water phase to the oil phase and homogenizes.
After homogenization, the cooling process begins. When the temperature of 38 ° is reached, add DMDM hydantoin and fragrance. Disperse the metal salt. Continue mixing until homogeneous.
Formulations 1 and 2 (comparative examples) are prepared on the same day, except that there is no added metal salt. Formulations 3 and 3a are prepared in the same manner, except that the silicone oil
(dimethylpolysiloxane) is included in the oil phase and in formulation 3, there is no salt of such metal.
The formulations are compared on the basis of consistency on the skin sensation. Formulations Ia, IB, 2a, 3a, ID, IE, IF e 1G were found to have a superior consistency and provide an improved silky skin feel compared to formulas 1, 2, 3 which do not have the metal salts added and the formulation 1C has not been compared, which already has a relatively high level of added metal salt.
Examples 4 and 4a Oil-in-Water Emulsions
The quantities in the above table are given as a percentage by weight of the final formula.
The above formulations are prepared in oil-in-water emulsions and the metal salt (here zinc oxide) and secreted once the emulsion is complete. The metal salt does not enter the oil phase of the emulsions to a significant degree and therefore does not react with the fatty acids. The formulations are prepared as follows:
Party? (Water phase)
Add water to the main container and start stir and boil;
Add the triethanolamine and continue mixing until the temperature reaches 80 ° C.
Part B (Oil Phase)
side bowl add shea butter
Add white beeswax
Add Stearic Acid
Add Glyceryl Oleate
Add Mineral Oil
Add Petrolatum
Heat and mix until homogeneous and reach a temperature of 80 ° C.
Part C
When both phases have reached 80 ° C, slowly add the oil phase, the water phase and homogenize. After homogenization, cool while stirring. When the temperature is below 40 ° C, add DMDM hydantoin in fragrance. Disperse the zinc oxide of the formulation 4A. Continue mixing until homogeneous.
The formulations are compared on the basis of consistency and skin feel. Formulation 4a was found to have a superior consistency and provide an improved skin feel compared to Formulation 4, which does not have the added metal salt.
Claims (28)
1. A formulation for skin care comprising: (i) cosmetically acceptable polyvalent metal cations; (ii) cosmetically acceptable long chain acids capable of forming a soluble salt with a polyvalent metal cation; (iii) a cosmetically acceptable water-insoluble oil component; wherein the polyvalent metal cation is prevented in a substantial reaction with the long chain acid while it is in the formulation, but with the application of the formulation to the skin and the rinsing with water is capable of reaction with the chain acid long to form a thin layer of insoluble precipitate on the skin.
2. The formulation as claimed in clause 1, characterized in that the polyvalent metal cations are selected from the group consisting of Ca ++, Zn ++, Mg ++, Al +++, and combinations of any two or more of these.
3. The formulation as claimed in clause 1, characterized in that the polyvalent metal cations are provided in the form of a cosmetically acceptable water soluble salt.
4. The formulation as claimed in clause 3, characterized in that the salts are selected from the group consisting of the group consisting of calcium chloride, zinc acetate, zinc oxide, zinc acetate, magnesium sulfate and combinations of any of 2 or more of these.
5. The formulation as claimed in clause 1, characterized in that the long chain acids are C 12-40 fatty acids.
6. The formulation as claimed in clause 5, characterized in that the fatty acids are saturated fatty acids.
7. The formulation as claimed in clause 6, characterized in that the fatty acids include one or more selected from the group consisting of palmitic acid, stearic acid, or ceric acid.
8. The formulation as claimed in clause 1, characterized in that the cosmetically acceptable water-insoluble oil component comprises one or more ingredients selected from the group consisting of (i) cosmetically acceptable hydrocarbon oils and (ii) fatty acid esters and long straight chain alcohols.
9. The formulation as claimed in clause 1, characterized in that the cosmetically acceptable water-insoluble oil component comprises one or more ingredients selected from the group consisting of mineral oil, petrolatum, beeswax and polar wax.
10. The formulation as claimed in clause 3, characterized in that the cosmetically acceptable salt (s) or the long chain acid or acids are coated or encapsulated.
11. The formulation as claimed in clause 1, characterized in that it comprises less than 20% water by weight.
12. The formulation as claimed in clause 3, characterized in that the salt is added to the formulation after the aqueous components and the oil are essentially combined.
13. The formulation as claimed in clause 1 characterized in that the formulation for skin care is an emulsion.
14. The formulation as claimed in clause 13, characterized in that it is a water-in-oil emulsion.
15. The formulation as claimed in clause 14, characterized in that it comprises a mixture of surfactants having a combined lipophilic hydrophilic balance of less than 8.
16. The formulation as claimed in clause 3, characterized in that it comprises by weight: (i) 0.01% to 2% cosmetically acceptable water soluble salt of polyvalent metal ion; (ii) 2 to 10% long chain fatty acids; (iii) 25-60% cosmetically acceptable oil component; wherein the cosmetically acceptable water soluble salt is prevented from reacting in long chain acid prior to application.
17. The formulation as claimed in clause 16, characterized in that it further comprises 3-10% surfactant and 30-60% hydrophilic component having one or more ingredients selected from the group consisting of water, ethanol, isopropanol, propylene glycol and glycerol; wherein the cosmetically acceptable water soluble salt is added after the emulsion has been formed.
18. The formulation as claimed in clause 17 characterized in that the emulsion is water-oil comprising by weight: (i) 0.05-1% of a cosmetically acceptable salt of a polyvalent metal ion selected from the group consisting of calcium chloride, zinc citrate, zinc chloride, zinc oxide, zinc acetate, and magnesium sulfate; (ii) 1-8% of saturated fatty acids Ci6-3o (iii) 2-10% beeswax, polar wax or mixtures thereof; -30% mineral oil; (v) 20% petrolatum; (vi) 0.5-5% of straight chain alcohols C12-34; (vii) 30-45% deionized water; (viii) 2-10% propylene glycol, glycerin or mixtures thereof; (ix) 2-5% of lipophilic surfactant; (x) 1-3% hydrophilic surfactant; (xi) 0.1-1% preservatives and / or antioxidants; wherein the cosmetically acceptable salt has been added after the emulsion has already been formed.
19. The formulation as claimed in clause 1, further characterized in that it comprises one or more of 0.1-2% fragrance and / or 0.05-0.5% colorant.
20. The formulation as claimed in clause 1, characterized in that it comprises an effective amount of a pharmaceutically or cosmetically active agent.
21. The formulation as claimed in clause 19, characterized in that the pharmaceutically or cosmetically active agent is selected from skin softening agents, vitamins, antibacterial agents, sunscreen agents and combinations thereof.
22. The formulation as claimed in clause 20, characterized in that the pharmaceutically or cosmetically active agent is a skin-relieving agent.
23. The formulation as claimed in clause 22, characterized in that the skin relieving agent is shea butter.
24. A process for the preparation of a skin care formulation as claimed in clause 1, comprising preparing an emulsion comprising hydrophilic components, lipophilic components and surfactants, and adding a water soluble salt of an ion of polyvalent metal to the emulsion.
25. The process as claimed in clause 24, characterized in that the formulation for skin care is a water-in-oil emulsion and the process comprises: (i) mixing the water-soluble components of the formulation, excluding the salt, together with one or more hydrophilic surfactants; and separately mixing the lipophilic components, together with one or more lipophilic surfactants, at a temperature where the components are liquid; (ii) adding the mixture of water-soluble components to the lipophilic mixture and homogenizing to form a water-in-oil emulsion; (iii) cooling the emulsion; (iv) adding the polyvalent metal ion salt to the emulsion and mixing so that the salt is suspended in the oil phase of the water-in-oil emulsion.
26. A skin care formulation prepared by the process as claimed in clause 25.
27. A method for moistening, protecting and / or conditioning the skin comprising applying to the skin a skin care formulation of clause 1 to the skin and rinsing with water.
28. A method for delivering a pharmaceutically or cosmetically active agent to the skin which comprises applying to the skin a skin care formulation according to clause 20 and rinsing with water. SUMMARIZES The moisturizing formulations of the skin can be administered in the bath or shower, depositing a thin layer of moisturizing agents with the application, which are not rinsed out but remain to protect the skin from drying, resulting in a softer skin feeling and more smooth; The formulations comprise polyvalent metal cations and fatty acids, which react with the application in the shower or bath to form a thin deposit of insoluble salts, thereby improving the retention of moisturizing oils and conditioning agents.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10976100 | 2004-10-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007004689A true MX2007004689A (en) | 2008-10-03 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1807043B1 (en) | Novel skin care formulation | |
TWI438007B (en) | Skin care preparation for external use | |
JP2023086619A (en) | emulsion composition | |
JP4637991B2 (en) | Microcapsule and manufacturing method thereof | |
JP7411421B2 (en) | cosmetics | |
TWI225405B (en) | Oil-in-water emulsion composition | |
JP2002029915A (en) | Skin cosmetic | |
JP2000016917A (en) | Skin whitening cosmetic | |
JP2002326920A (en) | Emulsion composition | |
JPH09291016A (en) | Hair cosmetic material | |
JPH0745387B2 (en) | Hair growth and hair growth promoter | |
TW202308591A (en) | Cosmetic | |
JP3565838B2 (en) | Hair treatment composition for bleaching agent or oxidative hair dye | |
JPH0196109A (en) | Skin-beautifying cosmetic | |
MX2007004689A (en) | Novel skin care formulation | |
JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives | |
EP2969031A1 (en) | Topical compositions for reducing aging effects | |
JPH10114642A (en) | Skin preparation for external use | |
JP2004277364A (en) | Foam cleansing preparation for sensitive skin | |
JPH01146815A (en) | External preparation for skin | |
JPH1179937A (en) | Skin lotion for pimple treatment | |
JP2000256168A (en) | Skin lotion | |
JP2860124B2 (en) | Hair cosmetics | |
JPH01238514A (en) | Skin cosmetic | |
JPS6259083B2 (en) |